Background
Most cases of Stevens–Johnson syndrome and toxic epidermal necrolysis are drug‐induced. A small subset of cases remain with unknown aetiology (idiopathic epidermal necrolysis [IEN]).
Objective
We sought to better describe adult IEN and understand the aetiology.
Methods
This retrospective study was conducted in 4 centres of the French national reference centre for epidermal necrolysis. Clinical data were collected for the 19 adults hospitalized for IEN between January 2015 and December 2019. Wide toxicology analysis of blood samples was performed. Histology of IEN cases was compared with blinding to skin biopsies of drug‐induced EN (DIEN, ‘controls’). Available baseline skin biopsies were analysed by shotgun metagenomics and transcriptomics and compared to controls.
Results
IEN cases represented 15.6% of all EN cases in these centres. The median age of patients was 38 (range 16–51) years; 68.4% were women. Overall, 63.2% (n = 12) of cases required intensive care unit admission and 15.8% (n = 3) died at the acute phase. Histology showed the same patterns of early‐ to late‐stage EN with no difference between DIEN and IEN cases. One toxicology analysis showed unexpected traces of carbamazepine; results for other cases were negative. Metagenomics analysis revealed no unexpected pathological microorganism. Transcriptomic analysis highlighted a different pro‐apoptotic pathway in IEN compared to DIEN, with an overexpression of apoptosis effectors TWEAK/TRAIL.
Conclusions
IEN affects young people and is a severe form of EN. A large toxicologic investigation is warranted. Different pathways seem involved in IEN and DIEN, leading to the same apoptotic effect, but the primary trigger remains unknown.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.